Similar articles

• In tough times, personalized medicine needs specific partners.

  Ballantyne C. Ballantyne C. Nat Med. 2008 Dec;14(12):1294. doi: 10.1038/nm1208-1294. Nat Med. 2008. PMID: 19057535 No abstract available.
• Prescription for an ailing pharmaceutical industry.

  Demain AL. Demain AL. Nat Biotechnol. 2002 Apr;20(4):331. doi: 10.1038/nbt0402-331. Nat Biotechnol. 2002. PMID: 11923826 No abstract available.
• The biotechnology industry: What's next?

  Guertin PA. Guertin PA. Biotechnol J. 2009 Aug;4(8):1124-31. doi: 10.1002/biot.200900126. Biotechnol J. 2009. PMID: 19685466 No abstract available.
• Genomics in Latin America: reaching the frontiers.

  Rabinowicz PD. Rabinowicz PD. Genome Res. 2001 Mar;11(3):319-22. doi: 10.1101/gr.179501. Genome Res. 2001. PMID: 11230156 Review. No abstract available.
• Environmental biotechnology in the postgenomics era.

  Chakrabarty AM. Chakrabarty AM. Biotechnol Adv. 2003 Dec;22(1-2):3-8. doi: 10.1016/j.biotechadv.2003.08.004. Biotechnol Adv. 2003. PMID: 14623038 Review.